Mitoxantrone, Etoposide, and Cytarabine (MEC) Plus Lenalidomide for Relapsed or Refractory Acute Myeloid Leukemia
Clinical trial NCT03118466 · COMPLETED
Trial details
- NCT number
- NCT03118466
- Sponsor
- Massachusetts General Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-25
- Primary completion
- 2019-08-29
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.